Near-Infrared Molecular Imaging of Glioblastoma by Miltuximab(®)-IRDye800CW as a Potential Tool for Fluorescence-Guided Surgery

Glioblastoma (GBM) is one of the most aggressive tumors and its 5-year survival is approximately 5%. Fluorescence-guided surgery (FGS) improves the extent of resection and leads to better prognosis. Molecular near-infrared (NIR) imaging appears to outperform conventional FGS, however, novel molecula...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancers (Basel)
Hlavní autoři: Polikarpov, Dmitry M., Campbell, Douglas H., McRobb, Lucinda S., Wu, Jiehua, Lund, Maria E., Lu, Yanling, Deyev, Sergey M., Davidson, Andrew S., Walsh, Bradley J., Zvyagin, Andrei V., Gillatt, David A.
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7226459/
https://ncbi.nlm.nih.gov/pubmed/32316186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12040984
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky